{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:57Z","timestamp":1790139417341,"version":"4.0.1"},"reference-count":24,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.18632\/oncotarget.16435","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T07:14:30Z","timestamp":1490166870000},"page":"50949-50957","source":"Crossref","is-referenced-by-count":41,"title":["mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group"],"prefix":"10.18632","volume":"8","author":[{"given":"Mariano","family":"Provencio","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GOTEL (Spanish Lymphoma Oncology Group)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Cantos","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Sab\u00edn","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gregorio Mara\u00f1on Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Quero","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Virgen de la Victoria Clinic University Hospital, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco R.","family":"Garc\u00eda-Arroyo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Pontevedra Hospital, Pontevedra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rueda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Costa del Sol Hospital, Marbella, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Maximiano","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delvys","family":"Rodr\u00edguez-Abreu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gran Canaria University Hospital, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IDIPHIM, University Hospital Puerta de Hierro Research Institute, Madrid, Spain"},{"name":"Molecular Oncology Laboratory, IdISSC, Clinico San Carlos University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"1","volume-title":"Pathology and genetics of tumors of haematopoietic and lymphoid tissues","author":"Vardiman","year":"2001"},{"key":"2","first-page":"731","article-title":"Molecular monitoring of cell-free circulating tumor DNA Non-Hodgkin Lymphoma","volume":"30","author":"Roschewski","year":"2016","journal-title":"Oncology"},{"issue":"13","key":"3","first-page":"328","article-title":"Intercellular communication: diverse structures for Exchange of genetic information","volume":"2012","author":"Sanchez-Madrid","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1078-0432.CCR-10-1489","article-title":"Exosomes and cancer: a newly described pathway of immune suppression","volume":"17","author":"Grizzle","year":"2011","journal-title":"Clin Cancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"14304","DOI":"10.3390\/molecules190914304","article-title":"Inhibition of the PI3K\/Akt\/mTOR Signaling Pathway in Diffuse Large B-Cell Lymphoma: Current Knowledge and Clinical Significance","volume":"19","author":"Smolewski","year":"2014","journal-title":"Molecules"},{"key":"6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-06-2184","article-title":"Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy","volume":"67","author":"Bonavida","year":"2007","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2016.11.052","article-title":"Activating AKT to inhibit JNK by troxerutin antagonizes radiation-induced PTEN activation","volume":"795","author":"Lu","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20062041","article-title":"Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma","volume":"204","author":"Campo","year":"2007","journal-title":"J Exp Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-\u03baB in diffuse large B-cell lymphoma","volume":"459","author":"Dalla-Favera","year":"2009","journal-title":"Nature"},{"key":"10","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/sj.onc.1210365","article-title":"Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo\/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions","volume":"26","author":"Bonavida","year":"2007","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jcp.2009.065227","article-title":"Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment","volume":"62","author":"Tzankov","year":"2009","journal-title":"J Clin Pathol"},{"key":"12","first-page":"37","article-title":"High grade B-cell lymphoma with rearrangements of MYC and BCL2 and\/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma","volume":"31","author":"Younes","year":"2016","journal-title":"Blood Rev"},{"key":"13","doi-asserted-by":"publisher","first-page":"38591","DOI":"10.18632\/oncotarget.5774","article-title":"MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management","volume":"6","author":"Young","year":"2015","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"crossref","first-page":"e8173","DOI":"10.1371\/journal.pone.0008173","article-title":"Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications","volume":"4","author":"Rodriguez","year":"2009","journal-title":"PLoS ONE"},{"key":"15","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Jack","year":"2010","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Gascoyne","year":"2009","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"15336","DOI":"10.1073\/pnas.1102855108","article-title":"Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3","volume":"108","author":"Wulf","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Staudt","year":"2011","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Fu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/sj.onc.1210448","article-title":"Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis","volume":"26","author":"Bonavida","year":"2007","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3109\/10428194.2012.656629","article-title":"Bortezomib in combination with R-DICE chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B cell lymphoma","volume":"53","author":"Furman","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"22","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Hiddemann","year":"1999","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gcc.22181","article-title":"Different exosome cargo from plasma\/bronchoalveolar lavage in non-small-cell lung cancer","volume":"53","author":"Bonilla","year":"2014","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T05:01:55Z","timestamp":1719118915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":24,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017,8,1]]}},"alternative-id":["16435","28881619"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16435","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]}}}